Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve
By Carly Helfand
FDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drug
By Berkeley Lovelace, Angelica Peebles & Berkeley Lovelace Jr.